The report covers detailed analysis and forecast for the injectable drug delivery market on a global and regional level from 2015 to 2021. The study offers historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study comprises a comprehensive view of the market with the review of market drivers, restraints, and opportunities. It also provides the level of impact of drivers and restraints on the injectable drug delivery market between 2015 and 2021. The study included a detailed competitive scenario and type portfolio of key vendors. The report evaluates Porter&rsquos Five Forces model to analyze the different factors affecting the growth of the injectable drug delivery market. Moreover, the study encompasses a market attractiveness analysis, which provides the most attractive and least attractive market segments information by end-user, type, and region. The report includes detailed segmentation of injectable drug delivery market based on type, end-user, and region. Devices and formulation are the key types in the injectable drug delivery market. On the basis... Research Beam Model: Research Beam Product ID: 1217211 4199 USD New
Injectable Drug Delivery Market (Device and Formulations) for Hospitals, Homecare and Other End-user: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Injectable Drug Delivery Market (Device and Formulations) for Hospitals, Homecare and Other End-user: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

 
 
 
The report covers detailed analysis and forecast for the injectable drug delivery market on a global and regional level from 2015 to 2021. The study offers historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study comprises a comprehensive view of the market with the review of market drivers, restraints, and opportunities. It also provides the level of impact of drivers and restraints on the injectable drug delivery market between 2015 and 2021.



The study included a detailed competitive scenario and type portfolio of key vendors. The report evaluates Porter&rsquos Five Forces model to analyze the different factors affecting the growth of the injectable drug delivery market. Moreover, the study encompasses a market attractiveness analysis, which provides the most attractive and least attractive market segments information by end-user, type, and region.



The report includes detailed segmentation of injectable drug delivery market based on type, end-user, and region. Devices and formulation are the key types in the injectable drug delivery market. On the basis of end-user segment, the market can be classified hospital, homecare, and others. Major regional segment analyzed in this report include North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India, and Brazil.



The report provides detailed competitive outlook including market share and company profiles of the key players operating in the global market. Some of the key participants in the report include Pfizer, Inc., Baxter International, Inc., Terumo Corporation, Becton, Dickinson and Company, Schott AG among others



This report segments the global injectable drug delivery market as follows:



Global Injectable Drug Delivery Market: Type Analysis





Device



Conventional Injection Devices

Self-Injection Devices





Formulations



Conventional Drug Delivery

Novel Drug Delivery

Others









Global Injectable Drug Delivery Market: End-user Segment Analysis





Hospitals

Home Care

Others





Global Injectable Drug Delivery Market: Regional Segment Analysis





North America



U.S.





Europe



Germany

France

UK





Asia Pacific



China

Japan

India





Latin America



Brazil





Middle East and Africa



Table of Content Chapter 1. Introduction 1.1. Report description and scope 1.2. Research scope 1.3. Research methodology 1.3.1. Market research process 1.3.2. Market research methodology Chapter 2. Executive Summary 2.1. Global injectable drug delivery market, 2015 – 2021 USD Billion) 2.2. Global injectable drug delivery market : Snapshot Chapter 3. Injectable Drug Delivery – Market Dynamics 3.1. Introduction 3.2. Market drivers 3.2.1. Global injectable drug delivery market drivers: Impact analysis 3.2.2. Increasing aging population 3.3. Market restraints 3.3.1. Global injectable drug delivery market restraints: Impact analysis 3.3.2. Possibility of needle infection and injuries 3.4. Opportunities 3.4.1. Increasing demand generic injactable 3.5. Porter’s five forces analysis 3.5.1. Bargaining power of suppliers 3.5.2. Bargaining power of buyers 3.5.3. Threat from new entrants 3.5.4. Threat from new substitutes 3.5.5. Degree of competition 3.6. Market attractiveness analysis 3.6.1. Market attractiveness analysis, by type segment 3.6.2. Market attractiveness analysis, by end-user segment 3.6.3. Market attractiveness analysis, by regional segment Chapter 4. Global Injectable Drug Delivery Market – Competitive Landscape 4.1. Company market share, 2015 (Subject To Data Availability) 4.1.1. Global injectable drug delivery market: company market share, 2015 4.2. Strategic Development 4.2.1. Acquisitions Mergers 4.2.2. New Type Launch 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures 4.2.4. Research and Development, Type and Regional Expansion 4.3. Product Portfolio Chapter 5. Global Injectable Drug Delivery Market – Type Analysis 5.1. Global injectable drug delivery market: Type overview 5.1.1. Global injectable drug delivery market revenue share, by type, 2015 - 2021 5.2. Device 5.2.1. Global injectable drug delivery market for device, 2015 - 2021 (USD Billion) 5.2.2. Conventional Injection Devices 5.2.2.1. Global injectable drug delivery market for conventional injection devices, 2015 - 2021 (USD Billion) 5.2.3. Self-Injection Devices 5.2.3.1. Global injectable drug delivery market for self-injection devices, 2015 - 2021 (USD Billion) 5.3. Formulations 5.3.1. Global injectable drug delivery market for formulations, 2015 - 2021 (USD Billion) 5.3.2. Conventional Drug Delivery 5.3.2.1. Global injectable drug delivery market for conventional injection devices, 2015 - 2021 (USD Billion) 5.3.3. Novel Drug Delivery 5.3.3.1. Global injectable drug delivery market for novel drug delivery, 2015 - 2021 (USD Billion) 5.3.4. Others 5.3.4.1. Global injectable drug delivery market for other, 2015 - 2021 (USD Billion) Chapter 6. Global Injectable Drug Delivery Market – End-User Analysis 6.1. Global injectable drug delivery market: End-user overview 6.1.1. Global injectable drug delivery market revenue share, by end-user, 2015 - 2021 6.2. Hospitals 6.2.1. Global injectable drug delivery market for hospitals, 2015 - 2021 (USD Billion) 6.3. Homecare 6.3.1. Global injectable drug delivery market for homecare, 2015 - 2021 (USD Billion) 6.4. Others 6.4.1. Global injectable drug delivery market for others, 2015 - 2021 (USD Billion) Chapter 7. Global Injectable Drug Delivery Market – Regional Segment Analysis 7.1. Global injectable drug delivery market: Regional overview 7.1.1. Global injectable drug delivery market revenue share, by region, 2015 - 2021 7.2. North America 7.2.1. North America injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion) 7.2.2. North America injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion) 7.2.3. U.S. 7.2.3.1. U.S. injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion) 7.2.3.2. U.S. injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion) 7.3. Europe 7.3.1. Europe injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion) 7.3.2. Europe injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion) 7.3.3. Germany 7.3.3.1. Germany injectable drug delivery market revenue, by type, 2015 - 2021, (USD Billion) 7.3.3.2. Germany injectable drug delivery market revenue, by end-user, 2015 - 2021, (USD Billion) 7.3.4. France 7.3.4.1. France injectable drug delivery market revenue, by type, 2015 - 2021, (USD Billion) 7.3.4.2. France injectable drug delivery market revenue, by end-user, 2015 - 2021, (USD Billion) 7.3.5. UK 7.3.5.1. UK injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion) 7.3.5.2. UK injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion) 7.4. Asia Pacific 7.4.1. Asia Pacific injectable drug delivery market revenue, by type, 2015 - 2021, (USD Billion) 7.4.2. Asia Pacific injectable drug delivery market revenue, by end-user, 2015 - 2021, (USD Billion) 7.4.3. China 7.4.3.1. China injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion) 7.4.3.2. China injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion) 7.4.4. Japan 7.4.4.1. Japan injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion) 7.4.4.2. Japan injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion) 7.4.5. India 7.4.5.1. India injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion) 7.4.5.2. India injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion) 7.5. Latin America 7.5.1. Latin America injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion) 7.5.2. Latin America injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion) 7.5.3. Brazil 7.5.3.1. Brazil injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion) 7.5.3.2. Brazil injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion) 7.6. Middle East and Africa 7.6.1. Middle East and Africa injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion) 7.6.2. Middle East and Africa injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion) Chapter 8. Company Profile 8.1. Pfizer, Inc. 8.1.1. Overview 8.1.2. Financials 8.1.3. Product portfolio 8.1.4. Business strategy 8.1.5. Recent developments 8.2. Baxter International Inc. 8.2.1. Overview 8.2.2. Financials 8.2.3. Product portfolio 8.2.4. Business strategy 8.2.5. Recent developments 8.3. Terumo Corporation 8.3.1. Overview 8.3.2. Financials 8.3.3. Product portfolio 8.3.4. Business strategy 8.3.5. Recent developments 8.4. Becton, Dickinson and Company 8.4.1. Overview 8.4.2. Financials 8.4.3. Product portfolio 8.4.4. Business strategy 8.4.5. Recent developments 8.5. Schott AG 8.5.1. Overview 8.5.2. Financials 8.5.3. Product portfolio 8.5.4. Business strategy 8.5.5. Recent developments 8.6. Sandoz 8.6.1. Overview 8.6.2. Financials 8.6.3. Product portfolio 8.6.4. Business strategy 8.6.5. Recent developments 8.7. Gerresheimer AG 8.7.1. Overview 8.7.2. Financials 8.7.3. Product portfolio 8.7.4. Business strategy 8.7.5. Recent developments 8.8. Baxter International, Inc. 8.8.1. Overview 8.8.2. Financials 8.8.3. Product portfolio 8.8.4. Business strategy 8.8.5. Recent developments 8.9. Alkermes PLC 8.9.1. Overview 8.9.2. Financials 8.9.3. Product portfolio 8.9.4. Business strategy